Demographics, A1C Testing, and Medication Use of Mexican Americans and Mexicans With Diabetes

2019 ◽  
Vol 45 (2) ◽  
pp. 155-163
Author(s):  
Judith Aponte

Purpose The purpose of this study is to investigate diabetes rates among Mexicans 20 years and older living in the United States and Mexico in 2012 and 2016. Methods The national sample was the National Health and Nutrition Examination Survey (NHANES) 2011-2012, NHANES 2015-2016, Mexican National Health and Nutrition Survey 2012 (ie, Encuesta Nacional de Salud y Nutrición 2012 [ENSANUT 2012]), and ENSANUT de Medio Camino 2016 (ENSANUT-MC 2016). Sex, age, A1C testing, and medication use (insulin, oral hypoglycemic agents, and both) were examined among participants. Results Most participants in study were female (50.7%, 53.9%, and 57.2%) and were younger (61 years, 57 years, and 60 years). A1C testing was conducted more in the United States (69.6% and 82.6%) than in Mexico (9.5% and 15.1%). More Mexicans (73.1% and 67.8% vs 54.9% and 54.9%) were using oral hypoglycemic agents, while more Mexican Americans used insulin (12.6% and 11.6% vs 6.3% and 11.1%) and used both insulin and oral hypoglycemic agents (17.1% and 15.8% vs 6.6% and 8.7%). Conclusions By examining and highlighting the diabetes mellitus practices and standardization of A1C testing, providers will be able to better understand and address the rising rates of diabetes in the United States and Mexico while driving practice and policy changes.

Author(s):  
Molly R Petersen ◽  
Eshan U Patel ◽  
M Kate Grabowski ◽  
Charlotte A Gaydos ◽  
Thomas C Quinn ◽  
...  

Abstract Background Chlamydia trachomatis is the most common nationally notifiable sexually transmitted infectious disease in the United States; however, the seroprevalence of C. trachomatis infection is unknown. Methods This cross-sectional study was conducted among 1725 females aged 18-39 years who provided serum and urine samples in the 2013-2016 National Health and Nutrition Examination Surveys (NHANES). Presence of anti-C. trachomatis Pgp3 IgG was determined using both an enzyme-linked immunosorbent assay (ELISA) and multiplex bead array (MBA). Weighted seroprevalence estimates were calculated. Correlates of seroprevalence were examined by multivariable Poisson regression. Results In 2013-2016, overall seroprevalence of C. trachomatis Pgp3 IgG was 30.0%(95%CI=25.5%-35.0%) as measured by ELISA and 29.4%(95%CI=25.8%-33.0%) as measured by the MBA assay. Overall agreement between tests was 87.1%(1503/1725). There was a high positive agreement by the MBA assay with current detection of chlamydia in urine (86%[36/42]), a past-year diagnosis of chlamydia (82%[27/33]), and a history of treatment for pelvic inflammatory disease (61%[37/61]). Seroprevalence of C. trachomatis Pgp3 IgG, as measured by MBA, was significantly higher among non-Hispanic Blacks (68.0%; aPR=2.7[95%CI=2.3-3.3]), Mexican Americans (30.9%; aPR=1.5[95% CI=1.2-1.9]), and other Hispanics (35.0%; aPR=1.9[95%CI=1.4-2.5]) as compared to non-Hispanic Whites (21.4%). Seroprevalence was also associated with a higher lifetime number of sexual partners and a younger age at sexual debut. Conclusion Both the ELISA and MBA serologic assays revealed a high prevalence of antibodies to C. trachomatis Pgp3 in young adult females in the U.S. household population. There were major racial/ethnic disparities in exposure to C. trachomatis, with increased vulnerability among non-Hispanic Blacks.


2013 ◽  
Vol 55 (Supl.4) ◽  
pp. 451 ◽  
Author(s):  
Sylvia Guendelman ◽  
Miranda Lucia Ritterman-Weintraub ◽  
Lia C Haskin-Fernald ◽  
Martha Kaufer-Horwitz

Objective. To examine actual and perceived weight in national cohorts of Mexican-origin adult men in Mexico and the United States (US). Materials and methods. We used the 2001-06 National Health and Nutrition Examination Survey and the 2006 Mexican National Health and Nutrition Survey. Results. The prevalence of overweight or obesity (OO) in Mexicans was 65% and in Mexican-Americans was 72%. OO Mexican-American men were more likely than OO Mexican men (56 vs. 49%) to perceive themselves as “overweight”. Among OO men from both populations, those who had been screened for OO by a health provider were almost seven times more likely to have accurate weight perceptions. Only 9% of OO men in Mexico and 25% in the US recalled having been screened for weight. Conclusion. Weight misperceptions were common in both populations but more prevalent in Mexico; low screening by providers may contribute to poor weight control in both countries


Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 2952
Author(s):  
Yong Zhu ◽  
Neha Jain ◽  
Vipra Vanage ◽  
Norton Holschuh ◽  
Anne Hermetet Agler ◽  
...  

This study examined differences in dietary intake between ready-to-eat cereal eaters and non-eaters in adults from the United States. Participants (n = 5163) from the National Health and Nutrition Examination Survey 2015–2016 were included. One-day dietary recall was used to define ready-to-eat cereal consumption status and estimate dietary intake in eaters and non-eaters. Data from Food Patterns Equivalent Database 2015–2016 were used to compare intakes of food groups by consumption status. Diet quality was assessed by Healthy Eating Index 2015. Nineteen percent of US adults were ready-to-eat cereal eaters; they had a similar level of energy intake as non-eaters, but they had significantly higher intake of dietary fiber, and several vitamins and minerals, such as calcium, iron, magnesium, potassium, zinc, vitamin A, thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, and vitamin D. They were also more likely to meet nutrient recommendations. Compared to non-eaters, ready-to-eat cereal eaters had the same level of added sugar intake but they had significantly higher intake of whole grains, total fruits, and dairy products. The diet quality of ready-to-eat cereal eaters was significantly higher than that of non-eaters. The study supports that ready-to-eat cereal eaters have better dietary intake with a healthier dietary pattern than non-eaters in the United States.


Sign in / Sign up

Export Citation Format

Share Document